Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -308.50K | -317.20K | -716.70K | -715.30K | -426.60K |
| Total Depreciation and Amortization | 22.90K | 23.50K | 24.60K | 24.60K | 24.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -459.80K | -472.80K | 485.10K | 484.10K | -376.30K |
| Change in Net Operating Assets | -342.90K | -352.60K | -- | -- | -127.10K |
| Cash from Operations | -1.09M | -1.12M | -207.00K | -206.60K | -905.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.10K | -5.30K | -- | -- | -- |
| Cash from Investing | -5.10K | -5.30K | -- | -- | -- |
| Total Debt Issued | 465.80K | 465.80K | -- | -- | -- |
| Total Debt Repaid | -19.60K | -19.60K | -18.90K | -18.90K | -18.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 3.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -303.10K |
| Cash from Financing | 290.70K | 298.90K | -12.40K | -12.40K | 1.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -802.80K | -825.50K | -219.40K | -219.00K | 859.00K |